Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

449 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

NCT02581189

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

NCT02725866

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation

NCT03053180

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: South-Ural State Med. Academy Chelyabinsk, Russia

KOGBUZ Kirovsk Infect Hosp Kirov, Russia

Specialized Clinical Infectiou Krasnodar, Russia

Orenburg Regional Clinical Hos Orenburg, Russia

View Trial Details

Completed

An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C

NCT01604291

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Haemek Hospital; Gastroenterology Afula, Israel

Barzilai MC; Gastroenterology Ashkelon, Israel

Soroka Medical Center; Gastroenterology Beersheba, Israel

Hillel Yaffe Hospital; Gastroenterology Hadera, Israel

View all 21 locations

View Trial Details

Completed

Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania

NCT02807402

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related

NCT03313154

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +21 more
Locations: Policlinico Universitario di Monserrato Monserrato, Cagliari, Italy

View Trial Details

Completed

8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis

NCT03186365

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Kaohsiung Medical University Hospital Kaohsiung City, Taiwan

View Trial Details

Completed

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study

NCT02798315

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection

NCT03098121

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Taoyuan general hospital Taoyuan, Taiwan

View Trial Details

Completed

The Physiology of Fatigue in Patients With Chronic Liver Disease

NCT01867385

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details